A prospective study of the persistence of Mycoplasma pneumoniae antibody levels.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000372:Agglutination Tests; D000373:Agglutinins / Q000032:analysis; D000907:Antibodies, Bacterial / Q000032:analysis*; D001323:Autoantibodies / Q000032:analysis; D003080:Cold Temperature; D003168:Complement Fixation Tests; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007158:Immunologic Techniques; D008297:Male; D008623:Mercaptoethanol; D008875:Middle Aged; D009174:Mycoplasma / Q000276:immunology*; D009175:Mycoplasma Infections / Q000276:immunology* / Q000628:therapy; D011014:Pneumonia / Q000276:immunology* / Q000628:therapy; D011446:Prospective Studies; D013752:Tetracycline / Q000627:therapeutic use; D013997:Time Factors
D000373:Agglutinins; D000907:Antibodies, Bacterial; D001323:Autoantibodies; D008623:Mercaptoethanol; D004917:Erythromycin; D013752:Tetracycline